Favorable effects of glycolate conjugation on the biodistribution of humanized antiTac Fab fragment

Hisataka Kobayashi, Kim In-Sook, Debbie Drumm, Meyoung-Kon Kim, David S. Paik, Nhat Le, Thomas A. Waldmann, Jorge A. Carrasquillo, Chang H. Paik

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

One of the major limitations of using intact immunoglobulins for targeting tumors is poor penetration into tissues. Although Fab fragments have been used because of their improved kinetics, they have undesirable high renal accumulation. In this study we tested a new approach to block renal accumulation of Fab. Methods: We conjugated humanized antiTac Fab fragments, which are directed against the interleukin-2 receptor, with glycolate. The biodistribution, pharmacokinetics and catabolism of glycolated Fab (glyco- Fab) were evaluated at two different levels of substitution (heavy and light) compared with nonglycolated Fab in Tac-antigen-positive (ATAC4) and -negative (A431) tumor-bearing nude mice. The mice received coinjections of 125I- labeled glyco-Fab (3 μCi/1 μg) and 131I-labeled nonglycolated Fab (5 μCi/1 μg). In addition, groups of mice receiving these reagents were also coinfused with 50 mg L-lysine. Results: Significantly less glyco-Fab than nonglycolated Fab accumulated in the kidney (21 versus 189 %ID/g; P < 0.001). A higher proportion of glyco-Fab was excreted into the urine in its intact form. The glyco-Fab survived longer in circulation than nonglycolated Fab. The peak tumor accumulation of glyco-Fab was 2.3-fold greater than that of nonglycolated Fab. Furthermore, the ATAC4 tumor-to-normal tissue ratio of glyco-Fab was much higher in all organs than that of nonglycolated Fab. The heavily glyco-Fab accumulated less in the kidney than the lightly glyco-Fab. The coinjected lysine reduced the renal accumulation of both nonglycolated Fab and glyco-Fab. Conclusion: Glyco-Fab is a promising agent because of its lower renal accumulation, higher tumor uptake and higher tumor-to-normal tissue ratio.

Original languageEnglish
Pages (from-to)837-845
Number of pages9
JournalJournal of Nuclear Medicine
Volume40
Issue number5
Publication statusPublished - 1999 May 1
Externally publishedYes

Keywords

  • Fab fragment
  • Glycolate
  • Monoclonal antibody
  • Radioimmunodetection

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Favorable effects of glycolate conjugation on the biodistribution of humanized antiTac Fab fragment'. Together they form a unique fingerprint.

  • Cite this

    Kobayashi, H., In-Sook, K., Drumm, D., Kim, M-K., Paik, D. S., Le, N., Waldmann, T. A., Carrasquillo, J. A., & Paik, C. H. (1999). Favorable effects of glycolate conjugation on the biodistribution of humanized antiTac Fab fragment. Journal of Nuclear Medicine, 40(5), 837-845.